Monash IVF GroupASX:MVF 76 Market Cap is A$276.6 Mil as of Jun. 27, 2026. GuruFocus rates ASX:MVF with a GF Score™ of 76/100 and a GF Value™ of A$1.39 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 219 Medical Diagnostics & Research companies, Monash IVF Group ranks better than 61.64% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Monash IVF Group's share price for the quarter that ended in Dec. 2025 was A$0.735. Monash IVF Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 389.6 Mil. Therefore, Monash IVF Group's market cap for the quarter that ended in Dec. 2025 was A$286.4 Mil.
Monash IVF Group's quarterly market cap
declined
from Dec. 2024 (A$494.8 Mil) to Jun. 2025 (A$274.7 Mil) but then
increased
from Jun. 2025 (A$274.7 Mil) to Dec. 2025 (A$286.4 Mil).
Monash IVF Group's annual market cap
increased
from Jun. 2023 (A$446.1 Mil) to Jun. 2024 (A$500.7 Mil) but then
declined
from Jun. 2024 (A$500.7 Mil) to Jun. 2025 (A$274.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Monash IVF Group's Enterprise Value for Today is A$470.2 Mil.
Monash IVF Group (ASX:MVF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Monash IVF Group Market Cap Related Terms
Monash IVF Group Market Cap Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Monash IVF Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Monash IVF Group's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (ASX:MVF) has a Market Cap of A$276.6 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Monash IVF Group and its competitors. According to the industry distribution chart, Monash IVF Group ranks #84 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 38.4%.
Is Monash IVF Group's Market Cap too high?
Monash IVF Group's current Market Cap is A$276.6 Mil. Based on the distribution chart, Monash IVF Group ranks #84 out of 219 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Monash IVF Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #84 out of 219 companies for Market Cap. This puts Monash IVF Group in the upper half of its industry. The industry median Market Cap is 55.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 55.76, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Monash IVF Group and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 55.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monash IVF Group's current Market Cap is A$276.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Based on GuruFocus' analysis, Monash IVF Group (ASX:MVF) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.39, compared to a current price of A$0.71 — trading 48.9% below its estimated fair value. The current Market Cap is A$276.6 Mil. Monash IVF Group's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Monash IVF Group (ASX:MVF), the current Market Cap is A$276.6 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (ASX:MVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of A$0.71 is trading 48.9% below its estimated GF Value™ of A$1.39.
GuruFocus considers Monash IVF Group to be Possible Value Trap.
Key valuation signals for ASX:MVF:
Market Cap: A$276.6 Mil
GF Value™: A$1.39 vs. price of A$0.71 (48.9% below fair value)
No single metric tells the full story. See the ASX:MVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
76GF Score
Get the complete analysis for ASX:MVF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MVF has been successfully added to your 
